Document is current

Any future updates will be listed below

Correction: Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic

Crossref DOI link: https://doi.org/10.1038/s44276-026-00217-x

Published Online: 2026-04-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark